title: Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response.
abstract: An experimental system involving injections of ovalbumin (OVA) and ferritin (FER) in Freund's incomplete adjuvant (FIA) into the right and left flank skin folds of sheep was used to study the influence of the FIA/antigen depot and the draining lymph node in maintaining an antibody response. Excision of the injection granuloma and draining lymph node from one side 2-3 months after injections resulted in a profound decrease in serum antibody titres. This response was observed in all eight sheep in the experimental group. In five of eight animals in another experiment, excision of the injection sites had no appreciable effect on antigen-specific antibody titres when compared with antibody specific for antigen on the intact side of the sheep. In the remaining three animals, excision of the injection site did cause some fall in titre. Radiotracer studies revealed that about one-third of the original [125I]OVA/FIA injected was present in the granuloma 20 weeks after injection. Lymphatic cannulation approaches were used to study the responsiveness of the lymph node draining an FIA/antigen granuloma established 12 weeks earlier and showed that increments of 1-2 mg OVA in saline administered adjacent to the granuloma at 6-7 day intervals gave rise to strong anti-OVA containing cell (AOCC) responses in lymph. There were 2-6-fold increases in serum antibody titre in response to 3-5 doses of OVA or FER (1-2 mg) in saline injected adjacent to the FIA/antigen injection site (which had been administered 14-16 weeks previously). It is concluded that the release rate of antigen from a FIA/antigen depot is insufficient to sustain maximal antibody levels in blood serum.
authors.affiliation: CSIRO Division of Animal Health, McMaster Laboratory, Glebe, N.S.W. Australia.
authors.forename: A K
authors.initials: AK
authors.lastname: Lascelles
authors.forename: G
authors.initials: G
authors.lastname: Eagleson
authors.forename: K J
authors.initials: KJ
authors.lastname: Beh
authors.forename: D L
authors.initials: DL
authors.lastname: Watson
mesh_terms: D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000008:administration & dosage*; D005260:Female; D005293:Ferritins / Q000276:immunology; D005620:Freund's Adjuvant / Q000008:administration & dosage*; D006099:Granuloma / Q000209:etiology / Q000276:immunology; D007114:Immunization; D008198:Lymph Nodes / Q000276:immunology; D008297:Male; D010047:Ovalbumin / Q000276:immunology; D012756:Sheep; D013997:Time Factors
chemical_list: D000941:Antigens; D010047:Ovalbumin; D005293:Ferritins; D005620:Freund's Adjuvant